Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19

Conditions:   COVID-19;   SARS-CoV2 Interventions:   Biological: SAB-185;   Other: Normal Saline Sponsors:   SAb Biotherapeutics, Inc.;   Biomedical Advanced Research and Development Authority;   Joint Program Executive Office (JPEO) Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Enabling Biotechnologies (EB) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials